H&T Presspart will once again be attending this year’s Respiratory Drug Delivery Europe (RDD 2021) which will be held online as a virtual conference from 4-7 May.

H&T Presspart will host a virtual workshop entitled “Patient First: Innovation Meeting The Ever Increasing Expectations For Patient Interfacing, Safe, Cost Efficient Drug Delivery Through Product And Processes’ as well as having a stand in the digital exhibition hall.

Lead by Anselm Ebert, Business Development Director, and Thorsten Lehmann, Business Development Manager, the workshop will review product and process innovation with regard to inhalation devices, “old-school” vs. smarter devices, and how those solutions can reduce overall costs. The workshop will also explore improved patient interfacing via Connected Health. The question of whether “Ease of Use” excludes affordability will also be explored.

As well as the workshop, H&T Presspart will also be exhibiting a wide range of respiratory drug delivery components. Virtual attendees will be able to explore our range of metered-dose inhaler cans, actuators and dose counting solutions, as well as our patented Plasma surface treatment for MDI cans. The surface treatment was developed following the introduction of HFA propellants as a solution to the inherent problem of drug degradation and drug adhesion within the MDI canister.

H&T Presspart's Plasma internal surface treatment for MDI CansFor more information on the show or if you would like to get in touch an arrange meeting, please contact us.